Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336569 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT01336569: Completed Phase 4 study, sponsored by Alcon Research.
NCT01336569 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01336569, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.
Primary Outcome
As measured by Goldmann applanation tonometry. High IOP (outside the normal range) can be a risk factor for developing glaucoma or glaucoma progression (leading to optic nerve damage). A more negative change indicates a greater amount of improvement.
Interventions
- DRUG Travoprost 0.004%/timolol maleate 0.5% fixed combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
What the finished NCT01336569 record still lists
NCT01336569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Travoprost 0.004%/timolol maleate 0.5% fixed combination is the first listed.
NCT01336569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01336569 about?
NCT01336569 is a clinical study titled "Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol". The purpose of this study was to assess the safety and intraocular pressure (IOP)-lowering efficacy of changing to DuoTrav® from prior timolol 0.5% monotherapy in participants with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT01336569?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2011-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01336569?
The interventions under investigation include: Travoprost 0.004%/timolol maleate 0.5% fixed combination (DRUG).
Who is sponsoring clinical trial NCT01336569?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01336569's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia